FTC Declares Victory in Generic Drug Case

June 17 (Bloomberg) -- Drugmakers can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
China Stimulus Will Be `Incremental' All Year: Hofer
26:02 - Stefan Hofer, chief Asia investment strategist at BNP Paribas Wealth Management, talks about economies across Asia, global central banks' policies, and investment strategy. He speaks with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)
  • Why NY Daily News Might Sell to Cablevision for Only $1
  • Microsoft's Torossian Says Security `Top Priority'
  • American Companies Use the Nordic Track for Expansion